Sort
48,018 grants matching “immunotherapy”
Data Management and Analysis Core
$443,559Aris Floratos · Columbia University Health Sciences · U19 · FY2021 · AI
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
$443,556Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA
Elucidating the role of the Branched Chain Aminotransferases (BCATc and BCATm) as novel metabolic checkpoints of anti-lymphoma T cell immunity
$443,548Elitsa Antonova Ananieva-Stoyanova · Des Moines Univ Osteopathic Medical Ctr · R15 · FY2021 · CA
Blocking NK cell shedding of CD16a to increase cancer cell killing
$443,533Bruce K Walcheck · University Of Minnesota · R01 · FY2016 · CA
Molecular Mechanisms in Gastrointestinal Stromal Tumor
$443,533Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Targeting Small Nucleolar RNA Augments Immunotherapeutic Efficacy
$443,515Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
$443,482Alexander H. Stegh · Washington University · R01 · FY2022 · CA
Tumor-Targeted Multimodality Nanoscale Coordination Polymers for Chemo-Immunotherapy of Metastatic Colorectal Cancer
$443,479Wenbin Lin · University Of Chicago · R01 · FY2024 · CA
Clinical Fellowship Training Program
$443,471Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2017 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$443,412Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
$443,395Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Targeting defective necroptosis in colorectal cancer
$443,378Lin Zhang · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Development of a Theranostic Immunotherapy for Systemic Amyloidosis
$443,300Jonathan S Wall · University Of Tennessee Health Sci Ctr · R01 · FY2022 · DK
Project 3: Impact of tumor genetics on PDAC immunobiology and responses to macrophage-targeted immunotherapy
$443,282Edgar G. Engleman · Stanford University · P01 · FY2021 · CA
Multiplexed time domain fluorescence tomography of tumor biomarkers during immunotherapy
$443,281Anand T.n. Kumar · Massachusetts General Hospital · R01 · FY2022 · CA
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$443,269Mehmet Toner · Massachusetts General Hospital · R01 · FY2022 · CA
Microfluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsy
$443,269Mehmet Toner · Massachusetts General Hospital · R01 · FY2023 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$443,233Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$443,233Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
The Role of Schwann Cells in the Progression of Melanoma
$443,178Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Mechanistic insight into tumor-associated MUC1 glycopeptides binding to macrophage galactose-type lectin
$443,151Mare Cudic · Florida Atlantic University · R15 · FY2024 · CA
Targeting through Selective Cell Labeling
$443,066Cecilia Maria Leal · University Of Illinois At Urbana-Champaign · R01 · FY2021 · EB
Function of IL35+ B cells in pancreatic cancer
$443,047Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2022 · CA
Tuning peptide specifities for T cell tolerance in Type 1 diabetes
$442,995Mark S Anderson · University Of California, San Francisco · R01 · FY2024 · DK
Bioinformatics Technology to Characterize Tumor Infiltrating Immune Repertoires
$442,981Xiaole Shirley Liu · Dana-Farber Cancer Inst · U01 · FY2018 · CA